Nicole Labrosse
SVP, CHIEF FINANCIAL OFFICER · 3 filings · Latest: Feb 20, 2026
HALOZYME THERAPEUTICS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
HALO | Nicole Labrosse | SVP, CHIEF FINANCIAL OFFICER | Feb 23, 2026 | Option Exercise | $0.00 | 6,688 | — | 42,102 | |
HALO | Nicole Labrosse | SVP, CHIEF FINANCIAL OFFICER | Feb 20, 2026 | Option Exercise | $0.00 | 5,332 | — | 38,290 | |
HALO | Nicole Labrosse | SVP, CHIEF FINANCIAL OFFICER | Feb 16, 2026 | Option Exercise | $0.00 | 23,773 | — | 40,231 | |
HALO | NICOLE LABROSSE | — | Sep 10, 2025 | Proposed Sale | $76.07 | 22,227 | $1.7M | — |